Work in the current, and previous, Strategic Research Programmes has developed a new vaccine to control louping ill, a tick-borne disease primarily affecting sheep and red grouse. Louping ill causes significant economic losses for farmers and grouse estates in Scotland and is increasing in prevalence. Working together with key industry partners, and with funding from farming and moorland stakeholders, a novel approach is now being taken to commercialise the vaccine.